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Introduction
As part of a continuing effort to monitor the molecular
epidemiology of HIV-1 in northern Greece, in this study
we determined the genetic diversity and the prevalence
of drug resistance transmission among HIV-1 strains iso-
lated from 94 newly-diagnosed untreated consenting
patients in the period 2009 to 2010.
Materials and methods
Peripheral blood mononuclear cells (PBMC’s) and plasma
were collected from the patients at the AIDS National
Reference Laboratory of Northern Greece. Plasma RNA
encoding partial pol(protease and reverse transcriptase)
was amplified using TRUGENE HIV-1 genotyping assay
(Siemens). Antiretroviral drug resistance prevalence was
estimated by using the HIVseq program (HIV Drug Resis-
tance Database, Stanford University). PBMC’sD N A
encoding partial env(gp120) V3-loop region was amplified
by nested PCR and sequenced using an in-house tropism
assay at the Department of Biological Sciences, University
of Cyprus. Phylogenetic analysis was performed and trees
were constructed for each region by using neighbor-join-
ing with Kimura two-parameter method by means of
MEGA v5.0 software.
Results
The media age of patients is 32 years with the percentage
of male infection at 89.4%. The main risk groups were
homosexual contact (73.4%) and heterosexual contact
(17.0%). The phylogenetic analysis indicated B and A1 as
the dominant subtypes, 47.8% and 41,5% respectively,
followed by subtype C, CRF02_AG (3,2% each),
CRF04_cpx (2,1%) and subtypes F1 and G (1,1% each).
Twenty-one clusters showed epidemiologically linked
HIV-1 patients. Resistance mutations to protease inhibi-
tors were found in three individuals, while high resistance
associated mutations to reverse transcriptase inhibitors
(NRTI’s/NNRTI’s) were shown in sixteen patients. Trop-
ism testing indicated most of the HIV-1 strains as R5-tro-
pic (96%).
Conclusions
These newly found data demonstrate a heterogeneous epi-
demiological status of HIV-1 in northern Greece during
2009-2010, with subtype B and A1 being the dominant
subtypes in relation to the other subtypes. The prevalence
of antiretroviral resistance mutations is high among the
newly diagnosed untreated patients (17%) in comparison
with other European countries (10%).
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